Related by context. All words. (Click for frequent words.) 55 payor acceptance 54 payors 52 party administrators TPAs 51 party VLSI fabrication 50 party payor reimbursement 49 Payors 49 vii 48 organizations MCOs 48 administrator TPA 48 TriPath Oncology 47 iv 47 unfairly interferes 47 payer reimbursement 47 SANCTURA SANCTURA XR VANTAS 46 HYVISC R 46 Rosetta dependence 46 5 lipoxygenase inhibitor 45 healthcare payors 45 regarding Heska 45 hospitals physicians homecare 45 governmental approvals 45 ourability 45 Zanaflex Capsules 45 containing LABAs 45 successfully commercialize Silenor 45 DailyMed TM 45 XVII inability 45 reimbursement 45 AmeriHealth HMO Inc. 45 Bioenvision dependence 45 indemnity insurers 44 Alnylam dependence 44 vernakalant iv 44 substantial indebtedness 44 xvii 44 Auxilium anticipates 44 party semiconductor foundries 44 xii 44 without limitation 44 payor 44 DailyBreakNews.com 44 Sular formulation 44 affecting Amarin 44 Immtech scientists 44 Immtech clinical trials 44 affecting mortality morbidity 44 RAPTIVA R 44 viii 44 iii 44 novel therapeutic modality 43 xiv 43 Party Administrators TPAs 43 libel infringement 43 Shire plc Attention Deficit 43 NextRx subsidiaries provide 43 indemnitors 43 Biogold Fuels 43 related thereto 43 general economicconditions 43 STRIANT ® 43 xiii 43 HemoBioTech Annual Report 43 EGRIFTA TM 43 MethyPatch 43 Duska intends 43 PharMerica LTC Transaction 43 copays deductibles 43 xi Immtech ability 43 histrelin manufacturing marketing 42 vernakalant oral 42 Heska reliance 42 postretirement benefit 42 ourproducts 42 TRISENOX R 42 XP# XP# 42 iii Cubist 42 drawing painting gouache 42 VANTAS 42 work stoppages quarantines 42 InSite reliance 42 MMRGlobal Inc. 42 accounts HRAs 42 Ingenix OptumHealth 42 commercialize ZYFLO CR 42 #CL# 42 generic clopidogrel bisulfate 42 ability tosuccessfully 42 deploy MDCE services 42 Novogyne 42 Plenaxis R 42 reflect VIQ Solutions 42 franchisees licensees 42 Nortel unfunded 42 HospiScript Services LLC 42 capitated contracts 42 SUPPRELIN LA DELATESTRYL 42 Shire Attention Deficit 42 legal proceedings xxi 42 severe hypercholesterolemia 42 medigap 42 risksassociated 42 DIFICID ™ 42 TP# CETi 1 42 Physhield Insurance Exchange 42 anduncertainties 42 ZEGERID Capsules 41 pricing pressures 41 gastroenterologists endocrinologists 41 CUBICIN 41 reflecting Maximizer Software 41 manufacture RISPERDAL CONSTA 41 EPIX Pharmaceuticals 41 regulatory approvals 41 materially adversely affect 41 xv licensing 41 d SIGA 41 changesin 41 prescribe Seroquel 41 xxii 41 SOLODYN R 41 Daytrana TM 41 PPO HMO 41 markets HP Acthar 41 affecting BEO Bancorp 41 forodesine HCl 41 BioGold Fuels 41 GRANISOL 41 ERISA trumps 41 applicable regulatory approvals 41 cardinals donned Delly 41 BioSante licensees 41 PD2i Analyzer ™ 41 cicletanine 41 vii Cubist ability 41 PRAVACHOL R 41 incorporating FalconStor 41 consents authorizations 41 necessarily reflect Dawn.com 41 zileuton IV 41 Crisa acquisition 41 Somaxon ability 41 DIFICID 41 andrelated 40 AzaSite Plus 40 communicate differentiations effectively 40 PD2i Analyzer TM 40 Asentar TM 40 ELADUR 40 CorePharma LLC 40 LOPROX R 40 VIOXX Product 40 Sunesis clinical trials 40 Preferred Provider Organizations PPOs 40 forward lookingstatements 40 XOPENEX Inhalation Solution 40 orother 40 FalconStor OEM 40 Adalat CC 40 ii 40 FACTIVE tablets 40 differmaterially 40 LEP ETU 40 xxi 40 stockholder approvals 40 TRIOLEX HE# APOPTONE HE# 40 NCQA Accreditation 40 n h r 40 EHR Incentive Programs 40 mGluR2 mGluR4 mGluR5 mGluR7 40 FACTIVE R gemifloxacin 40 otherfactors 40 Prelude SkinPrep Systems 40 incur unanticipated 40 NeuroMove TM 40 Fingertip Formulary 40 valtorcitabine 40 periodically reassessed 40 MassHealth Medicaid 40 EMPOWER pivotal trial 40 Pharmacy Benefit 40 ResponseDX 40 y h 40 successfully commercialize Iluvien 40 copywriting Websites design 40 Solzira TM 40 Preferred Provider Organizations 40 Interest expense decreased 40 PREVU * LT 40 statementsregarding 40 Maintenance Organizations 40 xix 40 postemployment 40 ENTEREG 40 ZEGERID Powder 40 Paramount Vantage Paramount Classics 40 SILENOR 40 ADSI reliance 40 OrCrude TM process 40 Oxandrin 40 palonosetron hydrochloride injection 40 manufacture PolyHeme 40 payers 40 Zemiva ™ 40 Lamictal ODT 40 retrocessional coverage 40 nurse triage 40 DSL.net s 40 notlimited 40 adapt AVANT vectoring 40 prescribe Trileptal 40 successfully integrate 40 xxvi 40 HEDIS R 40 xxvii 40 chemosaturation system 40 pain relievers Duragesic 40 payor mix 40 HMOS 40 dimesylate Attention Deficit 40 PTNS therapy 40 affirmative covenants 40 MCOT TM 40 systemic immunosuppressive drugs 40 MRV networking 40 Acticoat TM products 40 Oxandrin R 39 TRISENOX ® 39 candidate AQ4N 39 Maxipime 39 NationsHealth 39 SBHCS 39 DELATESTRYL 39 capitated 39 XL# XL# XL# XL# 39 PLAVIX R 39 Flexible Spending Accounts FSAs 39 Licorice Products segment 39 pharmacy subsidiary PharmaCare 39 delinquencies defaults 39 NCQA accreditation 39 looking statementsaEUR describe 39 favoring downsizing deinstitutionalization 39 Synerx 39 plastic photochromic lens 39 Medicare Advantage 39 Rexahn licensees 39 y u 39 PolyHeme successfully 39 AVINZA 39 Inc. NASDAQ OMCL 39 Azedra TM Onalta TM 39 Ziarul Financiar va 39 SILENOR ™ 39 suchstatements 39 MBHO 39 PLAVIX R patent 39 CORLUX CORT # 39 NaviNet Insurer Connect 39 Monovisc 39 Congoleum undertakes 39 WFWS 39 DEFERRED INCOME TAX LIABILITIES 39 affect NYMET Holdings 39 commissions incidental damages 39 changes Decorize dependence 39 Prochieve R 39 VIOXX Lawsuits 39 risks anduncertainties 39 DMEPOS supplier 39 Magicalia Sites 39 ACTONEL 39 n h 39 Zemiva TM Trofex TM 39 SANCTURA R 39 peramivir clinical trials 39 governmental payors 39 SILENOR TM 39 Triage BNP Test 39 ® Medi Span 39 FavId 39 RXi Pharmaceutical Corporation 39 cosmetic cosmeceutical products 39 sites xix limitations 39 Clearant Process ® 39 include ClindaReach TM 39 UnitedHealthcare Ovations 39 SEBIVO 39 ix 39 Periostat 39 differ materially 39 PPO EPO 39 refinance indebtedness 39 shipping packing crating 39 torsemide ER 39 advance Debio 39 CareCentrix R 39 doxercalciferol 39 retain drilling rigs 39 contingent guaranties 39 Resident OneBill 39 including aseptic sauces 39 exposes InterMune 39 Nascobal R 39 guideline concordant 39 MediGap 39 HealthStream Research 39 thereby negatively impacting 39 CoTherix logo 39 #L Ozone Sterilizer 39 suchforward looking 39 Zemiva TM 39 Catasys TM 39 adversely affect Waste Connections 39 differ materiallyfrom 39 vi 39 Jyles Tucker midway 39 Lasertel subsidiary 39 reflect Ronn Motors 39 c SIGA 39 INTEGRILIN R eptifibatide Injection 39 LTCHs 39 Cautionary Disclosures 39 ZALBIN 39 unanticipated difficulties 39 risks associatedwith 39 multiple lease terminations 39 Protonix ® 39 refractory chronic lymphocytic 39 subsidiary PharmaCare 39 fwiggins@progress-index.com 39 y r 39 RUDDY 'S #s 39 Thelin tm 39 Acetavance TM 39 looking statements includingbut 39 render PolyHeme obsolete 39 CoStar stent 39 especially Copaxone ® 38 BlueOptions 38 DJSPU 38 theforward looking 38 h u 38 pharmacists nurse practitioners 38 DELETE OR EDIT COMMENTS 38 e h r 38 Sepracor anticipates 38 theseforward looking 38 merchant chargebacks 38 xi 38 DYNACIN R Tablets 38 KRYSTEXXA 38 BPE Segment 38 affecting ChinaNet 38 reinsurance recoverables 38 Sheets PHYH developer 38 joint Clairvest CEP 38 JunJing III 38 Staphylococcus aureus Immune Globulin 38 Inc. Nasdaq MEDE 38 MOZOBIL 38 adversely affect Linktone 38 i g 38 crolibulin TM 38 surety bonding increased 38 Ben Amrany 38 Medicare Advantage HMO 38 HMO POS 38 Email Encryption 38 o l 38 IoGen 38 indications Cytokinetics 38 Oracea TM 38 MGUs 38 NeutroSpec 38 p r 38 Therapeutic Antibodies segment 38 R Digirad Imaging 38 Inc. nyse AET 38 Inc. OTCBB AHOM 38 maydiffer materially 38 infringement invalidity 38 Kronos TiO2 38 Projects Initiation 38 benefit managers PBMs 38 Kerastick 38 CholeraGarde R Peru 38 transportation storage terminalling 38 TWYNSTA ® 38 Medisoft Clinical 38 Bioenvision disclaims any 38 software MeetingLinc LearnLinc 38 Medicare Advantage PPO 38 BioGlue ® 38 Through Glycoscience R 38 HealthAssurance 38 SUMAVEL 38 brentuximab vedotin pivotal 38 DailyMed ™ 38 STRIANT R 38 TRISENOX 38 xv 38 HMO PPO POS 38 looking statements.These 38 Medi CareFirst 38 Ovid UpToDate Medi Span 38 IVAX Diagnostics 38 regarding allosteric modulators 38 prescribers pharmacists 38 Medicare Advantage PFFS 38 looking statements 38 Lipitor Norvasc 38 limitedto 38 RAPTIVA 38 SIMOX SOI 38 areforward looking 38 historicalfacts 38 Pure Biofuels ability 38 Aetna HealthFund 38 VYVANSE TM lisdexamfetamine 38 Oxandrin ® 38 Bioaccelerate compounds under 38 currentexpectations 38 PSNs 38 efficiency ratio teb 38 Sensipar ® 38 Fortigel 38 Monovisc TM 38 CYCLOSET 38 productdevelopment 38 noticeably thinner stark 38 toreflect 38 ClindaReach ® 38 Corporation NASDAQ PGIC 38 LEVADEX ™ 38 opioid tolerance 38 ADVENTRX 38 mGluR4 mGluR2 38 Allovectin 7 R 38 REPLAGAL 38 expenses associated therewith 38 SilverTree Health 38 Medicare Special Needs 38 title taxation sociopolitical 38 Idenix anticipates 38 Synchronoss enables 38 expectations anticipations estimates 38 Somatuline R Depot 38 stock basedcompensation 38 insureds 38 cintredekin besudotox 38 Inc. Nasdaq PDII 38 AMEX ABL 38 RASP Data Security 38 NASDAQ CVV 38 Applehead I. 38 insured depositories 38 RightSourcing R 38 partner lorcaserin APD# 38 #L Sterilizer 38 Ketotransdel TM 38 Futureway Communications Inc. 38 Associa client 38 eTelcharge.com Inc. 38 Lexiscan R 38 cadence regulatory approvals 38 Assumptions underlying 38 t h r 38 gastrointestinal disorders ATI 38 Saxo Bank utilizes 38 Shire ADHD 38 orotherwise 38 postretirement benefit obligations 38 Kyowa Kirin 38 pricing IMPAX 38 aresubject 38 ResponseDX tests 38 xviii 38 activate telomerase 38 INTEGRILIN ® 38 IMGRC 38 lender consents 38 highly purified pasteurized 38 actuarially equivalent 38 hide reddened eyes 38 FEDVIP 38 f h 38 Company noncontributory defined 38 including withoutlimitation 38 NCQA Accredited 38 Rotarix R 38 formularies 38 website www.competitivetech.net 38 ProBiora3 ® 38 Hiru Corporation estimate 38 EXPENSES Employee Compensation 38 Solazed TM 38 Altoprev 38 SuperStitch R 38 work stoppages slowdowns 38 OraTest R 38 PerClot 38 Copegus R 38 d h 38 PocketScript e 38 EGRIFTA ™ 38 collect reinsurance recoverables 38 infringed misappropriated invalid 38 NSE SUNPHARMA 38 forecasted timelines 38 ii Immtech ability 38 Fodosine TM BCX 38 MGCD# MGCD# [001] 38 ELEVESS 38 www.TheNewATT.com 37 men bisexuals transgender 37 customers licensees licensors 37 results todiffer materially 37 commercialize NicVAX 37 hold E Hedger 37 Doral ® quazepam 37 without limitation Terremark 37 marketed satraplatin 37 g r 37 NxStage anticipates 37 website www.nyandcompany.com 37 radiotherapy radiosurgery proton therapy 37 results performance orachievements 37 PCB#.com shall bear 37 R Lotrel 37 ERISA pre emption 37 deductibles coinsurance 37 qui tam actions 37 Candente relies upon 37 refractory angina 37 visit http:/www.nationwide.com 37 peramivir BCX 37 Reinsurance recoverables 37 ACIs 37 Nasdaq NPSP announced 37 Ovid Medi Span 37 MVAS gross 37 PLAVIX ® 37 operated bakery cafe 37 Dismed 37 crinobulin 37 Mevacor OTC 37 subsidiaries Kindred Brookdale 37 Theragenics Corporation 37 Canvaxin TM 37 unabsorbed fixed overhead 37 reflect Ronn Motor 37 issue NaviNet fosters 37 Releasees 37 InformedRx 37 Illumigen Biosciences Inc. 37 NASDAQ SCRX specialty 37 uncertainties materialize Shire 37 Insolvency Proceedings 37 rheumatoid arthritis thrombocytopenia 37 SUPPRELIN LA 37 Peter Stalick 37 Anzemet 37 Risperdal schizophrenia drug 37 ™ pralatrexate injection 37 tizanidine hydrochloride short 37 any compensatory incidental 37 tortfeasors 37 providers 37 Radisson Embassy Suites 37 Specialty Pharmaceutical 37 dacetuzumab 37 materiality predictions 37 Pixelplus cautions readers 37 Retisert 37 c html plugins 37 supplemental Medigap 37 HMO 37 Medi Cal recipients 37 RAPTIVA r 37 relatedto 37 Medicare Advantage premiums 37 o h r 37 Increlex TM 37 Antibiotic resistant infections 37 CNMI Palau 37 candidate XP# 37 Airvana anticipates 37 adverse determinations 37 Rotarix ® 37 ApothecaryRx 37 racial slurs harassment 37 Community CCRx 37 include sutures needles 37 inherent uncertainty 37 RICK MAUCH 37 h g 37 CVS Caremark PBM 37 diagnostic radiopharmaceutical 37 ambulatory inpatient 37 develop electroporation 37 FERC MPSC NRC 37 oxandrolone USP 37 express Luminex 37 HealthRules 37 renal dysfunction acute renal 37 High Deductible 37 UBCI undertakes 37 HMOs PPOs 37 alpha interferons 37 semiconductor foundry assembly 37 Sunesis nonclinical studies 37 tarmac strandings Hanni 37 emailing @ gaflnews.com 37 PMPM 37 TrueKnowledge Platform TM 37 Yima project 37 Megace R ES 37 Thalomid ® 37 NCQA 37 Metabasis dependence 37 Hood Auctions 37 risksand uncertainties 37 Disproportionate Share 37 chocolate oatmeal raisin 37 Supplies DMEPOS 37 Mircette R 37 MAXY alpha 37 EVIZON TM squalamine lactate 37 SWHCS 37 xxv 37 Emtriva Viread 37 t r 37 ProSelect Insurance Company 37 GLASSIA 37 Trofile 37 tivozanib AV 37 Infor Cisco Systems 37 causeactual results 37 adopting SFAS #R 37 Inc. Phyhealth Pink 37 andgeneral 37 SCHIP Extension 37 BLVT BulovaTech 37 TRANSDUR Sufentanil 37 intents beliefs 37 developing ostarine selective 37 PETER PASSI covers 37 pulls Darvon painkiller 37 Thalomid R 37 h y 37 discourage frivolous lawsuits 37 IMPDH inhibitor 37 Familymeds 37 persistent muscle spasms 37 R DYNACIN R 37 AUCTIONEER CONSIGNOR OR 37 Medicaid HMO 37 CareKey 37 Nycomed GmbH 37 MCOs 37 Openwave breadth 37 Catasys 37 cbagley@californian.com 37 prescriber surveys 37 transactions contemplated 37 Manufacturer OEM 37 o h 37 ivpressonline.com 37 POHs 37 PERFECT TEETH 37 futureresults 37 SYCREST 37 OMNARIS HFA 37 TOCOSOL Camptothecin 37 APTIMA HPV assay 37 RESTASIS ® 37 Jeff Fedotin Packers.com 37 Charmer Charts shall 37 materially adversely affected 37 x Immtech 37 AzaSite TM 37 RxPertise 37 statements arebased 37 PBMs 37 uncollectable receivables 37 CalOptima 37 BlueChoice HealthPlan 37 Isis Alnylam 37 Inc NASDAQ CISG 37 Colo. Sess 37 TranSwitch indebtedness 37 Hyperactivity Disorder ADHD 37 Kosan dependence 37 HMOs 37 CLX Investments 37 Medicare Advantage Plans 37 botulin based 37 Rezulin diabetes 37 Medicago disclaims 37 xi unanticipated 37 v Nastech 37 PFFS 37 uncollectability 37 requirements xxii 36 Dynepo 36 cause actual 36 Chase Kishner 36 AERx ® 36 Accelr8 licenses 36 xxiii 36 healthplans 36 CDHP 36 CASE HOSPICE SUPPLIES 36 HEPLISAV TM hepatitis B 36 Cialis dosage 36 u h 36 Inovio Annual Report 36 h r i 36 Teflaro 36 Generx TM 36 vary materially 36 Cardizem CD 36 Prednisporin 36 refund guarantors 36 KRYSTEXXA TM 36 Entereg TM 36 Wellbutrin XL ® 36 substantiate CytoCore expectations 36 Tranzeo logo 36 telavancin NDA 36 miconazole MBT 36 Hiru Corporation cautions 36 theCompany 36 MyVax ® 36 intellectual property infringement 36 deductible coinsurance 36 Bio Imaging Technologies 36 viagra url = 36 ZYTO tm technology 36 Cellegy 36 intercompany arrangements 36 POSIDUR TM 36 changes SiriCOMM dependence 36 Hill Rom enhancing 36 r l 36 COLUMBIA Apex 36 HANA MAX 36 anticipated drydocking 36 FastFunds Financial Corporation 36 postretirement benefit plans 36 nucleoside analogues alone 36 assorted pigments resins 36 spinal stimulation 36 developments affecting SIAF 36 Rogallery.com 36 xxviii 36 AVINZA ® 36 bespectacled Lavallee Davidson 36 Inc. Nasdaq NHRX 36 Traci Arbios 36 customary closing conditions 36 HealthGate ability 36 inflammatory autoimmune diseases 36 nutrition Brotanek speculated 36 Stimulative monetary 36 CAUTIONARY STATEMENT Estimates 36 Mario Besta 36 Bioenvision disclaims 36 self insured retentions 36 Nitram Energy 36 LeapFrog SchoolHouse TM 36 concerning Alnylam 36 #.# subd [003] 36 BioGlue R 36 ResponseDX ™ 36 CSLR expectations 36 retrocessions 36 Unica disclaims any 36 purchaserâ € ™ 36 current physiologic opioid 36 parent SharkPage 36 AccessNET PACS 36 Preotact 36 MQ Associates 36 OxyContin Chernoff 36 MicroTel 36 qcushner@pulitzer.net 36 payor contracts 36 visit www.mmrglobal.com 36 http:/www.nansulate.com 36 Sea Logix 36 antipsychotic Zyprexa 36 exclusivity periods 36 commercialize Qutenza 36 novel synthetic PEGylated 36 include Alferon N 36 timelines communicated 36 reimburse THAC 36 persistency mortality 36 ActiveHealth 36 Dataworks disclaims 36 prolong QT interval 36 RAPIDGate Program contains 36 Wikifamilies 36 l o 36 novel L DOS# 36 Rufino Tamayo Francisco 36 CDO financings 36 withrespect 36 ENABLE Phase 2 36 Newsstand Distribution Services 36 NYSE Amex PTN 36 Edward V. Malysa 36 InsPro Enterprise 36 Equipment Prosthetics Orthotics 36 vii Dynamic 36 Azedra ™ 36 FQ = fiscal 36 IDTF 36 visit www.hfit.com 36 Taining Old Town 36 otherwise unlawful distasteful 36 Justin Belobaba President 36 Med eMonitor System 36 forwarda ^ looking 36 hyperinflationary environments 36 permitting timelines 36 indebtedness covenant 36 QNXT 36 vaginal lidocaine 36 acquisitions divestitures joint ventures 36 EHR EMR 36 vi Dot VN 36 l w 36 Quality Assurance NCQA 36 incorporate proprietary Microvolt 36 HepaGam B R 36 By Beth Sneller 36 HDHPs 36 MedicareAdvantage 36 Telemetry TM 36 DORATO RESOURCES INC. 36 Safe Harbor Disclosure 36 induce diuresis 36 Megace ES 36 representations warranties covenants 36 re imbursement 36 Item IA 36 pharmacokinetic feasibility 36 Exelixis compounds 36 ComfortScan system 36 arenot limited 36 Program FEHBP 36 AARP MedicareRx Saver 36 citywire.co.uk content requires 36 Trizytek 36 Emailwire.com ™ www.emailwire.com 36 reflect HRTE 36 servicemark risks xiii 36 painkiller Valium 36 RMHP 36 AnorMED expectation 36 PGP Acquisition 36 CapMed Patient Portal 36 Rarely Salmonella 36 Christopher McDougall Knopf 36 HMO PPO 36 Moly Mines suppliers 36 Nextlink Wireless Inc. 36 Aclasta Reclast 36 commercialization milestones 36 Navigator Serenic DonorVision Serenic 36 GearUpForSports makes 36 Sunrise Ambulatory Care 36 trojans rootkits worms 36 LocatePLUS Statements 36 adversely affect NetEase 36 MacroChem undertakes 36 Vioxx prescriptions 36 BioForce Nanosciences actual 36 Sylvia Leatham 36 shareholders@glancylaw.com 36 Smaller webcasters 36 inpatient rehabilitative healthcare 36 uncollectible accounts receivable 36 Acura Buick Cadillac 36 Eileen Auen 36 Announces Tentative Approval 36 ECU netbacks 36 Adjudicare 36 Clinical CareAdvance 36 PLAC Test 36 themanagement 36 lavender headscarf 36 Forecaster Rommel Yutuc 36 i# implanter 36 Infor expressly disclaims 36 should consult NeurogesX 36 Preclinical eValuation 36 Oncolin undertakes 36 Gotta Feeling Pump 36 visit www.forescout.com 36 Laurion cautions against 36 Aphthasol R 36 Resonator ™ device 36 Symphony tCGM 36 Hallums formerly 36 Eligard ® 36 consiste en 36 IntelliPharmaCeutics Ltd. 36 i #.# subds 36 didanosine associated 36 u t 36 infants Sundlof 36 www.ardenb.com 36 GrowthWorks refers 36 XL# anticancer compounds 36 operates CTS Teleradiology 36 Enpath ability 36 HEDIS ® 36 RR Donnelley disclaims 36 unanticipated drydock expenditures 36 Mirrus Systems 36 DCVax R Prostate 36 JUVISTA 36 consolidated VIEs 36 SeaBright Holdings 36 Commissions trailing 36 amlodipine beta blockers 36 ambulatory infusion pumps 36 Retalix undertakes 36 celgosivir 36 differ materially fromthose 36 Soliris TM eculizumab 36 AND ALL SALES 36 Newtek beliefs 36 MONOVISC 36 eRx NOW 36 reflect GuestLogix 36 Receives URAC 36 productsand services 36 Theseforward looking 36 Syntroleum Process 36 REVEAL Registry 36 successfully commercialize 36 india viagra 36 Puricase PEG uricase 36 Healthcare Effectiveness 36 Middletown Langhorne Langhorne 36 Al Sadeeq Mosque 36 parties unauthorized copying 36 Auxilium assessments 36 subjectto 36 Veronate R 36 PV module efficiencies 36 website www.chinamoney.com.cn 36 PROCHIEVE ® 36 w # yQ 36 andoperating 36 Coinsurance 36 theglobe.com inc 36 MultiCell bases 36 Accounts Receivable Financing Receivable 36 LE SN# 36 Insegia 36 workersa compensation 36 P. #a 36 update anyforward looking 35 vii IBC 35 OctoPlus licensed 35 Hiru Corporation 35 CalciTech products 35 Rasilez HCT 35 prudently incurred 35 highly acclaimed Serenic 35 information organizations RHIOs 35 nonacute 35 PHCS Network 35 Risks uncertainties 35 surgeons radiologists 35 Regence Engine 35 Imagewear coalition 35 LPM TM 35 Sevcon supplies 35 Cerashield TM 35 Symbicort asthma 35 CSLR expectations regarding 35 Surfaxin LS 35 Peach Bottom Limerick 35 Yucheng assumes 35 Agria beliefs 35 scale CGMP 35 objectives therefor 35 Argatroban 35 § #-#-# b [003] 35 calcium carbonate NPCC 35 tantalum lithium tin 35 Inovio pipeline 35 Modrenal R